Literature DB >> 2580025

Conserved group-specific epitopes of the circumsporozoite proteins revealed by antibodies to synthetic peptides.

U Vergara, A Ruiz, A Ferreira, R S Nussenzweig, V Nussenzweig.   

Abstract

The immunogenic properties of sporozoites are associated mainly with the circumsporozoite (CS) protein that covers the surface of mature sporozoites. This stage-specific protein has an immunodominant region with repetitive epitopes. Rabbits that are repeatedly immunized with sporozoites of Plasmodium knowlesi, a monkey malaria parasite, also recognize two synthetic peptides (N2 and C2) representing other polar domains of the CS protein. We show in this report that antibodies to the N2 and C2 synthetic peptides react not only with P. knowlesi but also with conserved regions of the surface membrane of other human, monkey, and rodent (but not avian) malaria sporozoites. Moreover, antibodies to N2 partially neutralize the infectivity of sporozoites of P. berghei, a rodent malaria parasite. In contrast, antibodies to synthetic peptides representing the repetitive epitope of P. knowlesi were strictly species specific.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2580025

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Predicted conformations for the immunodominant region of the circumsporozoite protein of the human malaria parasite Plasmodium falciparum.

Authors:  K D Gibson; H A Scheraga
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

2.  Immunogenicity of a non-repetitive sequence of Plasmodium falciparum circumsporozoite protein in man and mice.

Authors:  G Del Giudice; Q Cheng; D Mazier; N Berbiguier; J A Cooper; H D Engers; C Chizzolini; A S Verdini; F Bonelli; A Pessi
Journal:  Immunology       Date:  1988-02       Impact factor: 7.397

3.  Circumsporozoite protein of Plasmodium berghei: gene cloning and identification of the immunodominant epitopes.

Authors:  D J Eichinger; D E Arnot; J P Tam; V Nussenzweig; V Enea
Journal:  Mol Cell Biol       Date:  1986-11       Impact factor: 4.272

4.  Detection of human antibodies against Plasmodium falciparum sporozoites using synthetic peptides.

Authors:  G Del Giudice; A S Verdini; M Pinori; A Pessi; J P Verhave; C Tougne; B Ivanoff; P H Lambert; H D Engers
Journal:  J Clin Microbiol       Date:  1987-01       Impact factor: 5.948

5.  Human-human hybridomas secreting monoclonal antibodies to the Mr 195,000 Plasmodium falciparum blood stage antigen.

Authors:  R Schmidt-Ullrich; J Brown; H Whittle; P S Lin
Journal:  J Exp Med       Date:  1986-01-01       Impact factor: 14.307

6.  Expression in yeast of a Plasmodium vivax antigen of potential use in a human malaria vaccine.

Authors:  P J Barr; H L Gibson; V Enea; D E Arnot; M R Hollingdale; V Nussenzweig
Journal:  J Exp Med       Date:  1987-04-01       Impact factor: 14.307

7.  A full-length Plasmodium falciparum recombinant circumsporozoite protein expressed by Pseudomonas fluorescens platform as a malaria vaccine candidate.

Authors:  Amy R Noe; Diego Espinosa; Xiangming Li; Jordana G A Coelho-Dos-Reis; Ryota Funakoshi; Steve Giardina; Hongfan Jin; Diane M Retallack; Ryan Haverstock; Jeffrey R Allen; Thomas S Vedvick; Christopher B Fox; Steven G Reed; Ramses Ayala; Brian Roberts; Scott B Winram; John Sacci; Moriya Tsuji; Fidel Zavala; Gabriel M Gutierrez
Journal:  PLoS One       Date:  2014-09-23       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.